RSS-Feed abonnieren
DOI: 10.1055/s-0029-1237704
© J. A. Barth Verlag in Georg Thieme Verlag KG Stuttgart · New York
Long Term Follow-up of Patients with Adrenal Incidentalomas- A Single Center Experience and Review of the Literature
Publikationsverlauf
received 06.05.2009
first decision 01.07.2009
accepted 30.07.2009
Publikationsdatum:
23. Oktober 2009 (online)

Abstract
Introduction: Adrenal incidentalomas (AIs) constitute an emerging clinical entity due to the increased use of abdominal imaging for diagnostic purposes. Most often it consists of benign-nonfunctioning lesions and an increase in size during follow-up is reported in about 9% (0–26%), whereas their functional evolution is rare.
Materials and methods: Sixty-four patients (22 males and 42 females; mean age 61.6±1.2 years), with AIs and follow-up of 3.1±0.4 years (range 0–19) were retrospectively evaluated. The patients underwent basal and dynamic evaluation of the hypothalamic-pituitary-adrenal axis, renin-angiotensin-aldosterone system and adrenomedullary function. Mass enlargement and adrenal hyperfunction were estimated at yearly intervals.
Results: Adrenalectomy was performed in 5 patients (4 benign cortical adenomas and 1 pheochromocytoma). Abnormal manifestation, based on clinical, laboratory and histological evaluation, was observed in 4 patients [1 (1.56%) with SCS, 2 (3.12%) with pheochromocytoma and 1 (1.56%) with aldosteronoma], 3 of which were diagnosed at their initial evaluation and 1 at the 3rd year of follow-up. The remainders [60 patients (93.75%)] were harbouring a non-secretory mass (8 potential myelolipomas, 8 nodular hyperplasias, 3 cystic lesions). Eleven patients (17.2%) had bilateral AIs. Mass enlargement (5–13 mm) was observed in 9 patients (14%), ≥10 mm 4 (6.25%), while mass shrinkage (5–19 mm) in 3 (4.7%) during follow-up. No hormonal evolution was noticed.
Conclusions: AIs present usually as benign, non-secretory lesions. Criteria for surgical intervention were met at initial assessment for the majority of AIs. Size alterations during follow-up are uncommon and functional evolution is rare.
Key words
adrenal mass - adrenalectomy - aldosteronoma - Cushing's syndrome - incidentaloma - pheochromocytoma
References
- 1
Abecassis M, McLoughlin MJ, Langer B. et al .
Serendipitous adrenal masses: prevalence, significance, and management.
Am J Surg.
1985;
149
783-788
MissingFormLabel
- 2
Anagnostis P, Karagiannis A, Tziomalos K. et al .
Adrenal incidentaloma: a diagnostic challenge. Hormones (Athens).
2009;
8
163-184
MissingFormLabel
- 3
Barry MK, van Heerden JA, Farley DR. et al .
Can adrenal incidentalomas be safely observed?.
World J Surg.
1998;
22
599-603
MissingFormLabel
- 4
Barzon L, Scaroni C, Sonino N. et al .
Risk factors and long-term follow-up of adrenal incidentalomas.
J Clin Endocrinol Metab.
1999;
84
520-526
MissingFormLabel
- 5
Barzon L, Fallo F, Sonino N. et al .
Development of overt Cushing's syndrome in patients with adrenal incidentaloma.
Eur J Endocrinol.
2002;
146
61-66
MissingFormLabel
- 6
Barzon L, Sonino N, Fallo F. et al .
Prevalence and natural history of adrenal incidentalomas.
Eur J Endocrinol.
2003;
149
273-285
MissingFormLabel
- 7
Bastounis EA, Karayiannakis AJ, Anapliotou ML. et al .
Incidentalomas of the adrenal gland: diagnostic and therapeutic implications.
Am Surg.
1997;
63
356-360
MissingFormLabel
- 8
Bencsik Z, Szabolcs I, Góth M. et al .
Incidentally detected adrenal tumours (incidentalomas): histological heterogeneity
and differentiated therapeutic approach.
J Intern Med.
1995;
237
585-589
MissingFormLabel
- 9
Bornstein SR, Stratakis CA, Chrousos GP.
Adrenocortical tumors: recent advances in basic concepts and clinical management.
Ann Intern Med.
1999;
130
759-771
MissingFormLabel
- 10
Bülow B, Jansson S, Juhlin C. et al .
Adrenal incidentaloma – follow-up results from a Swedish prospective study.
Eur J Endocrinol.
2006;
154
419-423
MissingFormLabel
- 11
Caplan RH, Strutt PJ, Wickus GG.
Subclinical hormone secretion by incidentally discovered adrenal masses.
Arch Surg.
1994;
129
291-296
MissingFormLabel
- 12
Cerfolio RJ, Vaughan ED, Brennan TG. et al .
Accuracy of computed tomography in predicting adrenal tumor size.
Surgery.
1993;
176
307-309
MissingFormLabel
- 13
Dobbie JW.
Adrenocortical nodular hyperplasia: the ageing adrenal.
J Pathol.
1969;
99
1-18
MissingFormLabel
- 14
Funder JW, Carey RM, Fardella C. et al .
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An
Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab.
2008;
93
3266-3281
MissingFormLabel
- 15
Gopan T, Remer E, Hamrahian AH.
Evaluating and managing adrenal incidentalomas.
Cleve Clin J Med.
2006;
73
561-568
MissingFormLabel
- 16
Grossrubatscher E, Vignati F, Possa M. et al .
The natural history of incidentally discovered adrenocortical adenomas: a retrospective
evaluation.
J Endocrinol Invest.
2001;
24
846-855
MissingFormLabel
- 17
Grundy SM, Cleeman JI, Merz CN. et al .
Implications of recent clinical trials for the National Cholesterol Education Program
Adult Treatment Panel III guidelines.
Circulation.
2004;
110
227-239
MissingFormLabel
- 18
Grumbach MM, Biller BM, Braunstein GD. et al .
Management of the clinically inapperent adrenal mass (“incidentaloma”).
Ann Intern Med.
2003;
138
424-429
MissingFormLabel
- 19
Hamrahian AH, Ioachimescu AG, Remer EM. et al .
Clinical utility of noncontrast computed tomography attenuation value (hounsfield
units) to differentiate adrenal adenomas/hyperplasias from nonadenomas: Cleveland
Clinic experience.
J Clin Endocrinol Metab.
2005;
90
871-877
MissingFormLabel
- 20
Herrera MF, Grant CS, van Heerden JA. et al .
Incidentally discovered adrenal tumors: an institutional perspective.
Surgery.
1991;
110
1014-1021
MissingFormLabel
- 21
Kasperlik-Zaluska AA, Roslonowska E, Slowinska-Srzednicka J. et al .
1 111 patients with adrenal incidentalomas observed at a single endocrinological center:
incidence of chromaffin tumors.
Ann N Y Acad Sci.
2006;
1073
38-46
MissingFormLabel
- 22
Latronico AC, Chrousos GP.
Extensive personal experience: adrenocortical tumors.
J Clin Endocrinol Metab.
1997;
82
1317-1324
MissingFormLabel
- 23
Libè R, Dall’Asta C, Barbetta L. et al .
Long-term follow-up study of patients with adrenal incidentalomas.
Eur J Endocrinol.
2002;
147
489-494
MissingFormLabel
- 24
Luton JP, Martinez M, Coste J. et al .
Outcome in patients with adrenal incidentaloma selected for surgery: an analysis of
88 cases investigated in a single clinical center.
Eur J Endocrinol.
2000;
143
111-117
MissingFormLabel
- 25
Manassero F, Pomara G, Rappa F. et al .
Adrenal myelolipoma associated with adenoma.
Int J Urol.
2004;
11
326-328
MissingFormLabel
- 26
Mansmann G, Lau J, Balk E. et al .
The clinically inapparent adrenal mass: update in diagnosis and management.
Endocr Rev.
2004;
25
309-340
MissingFormLabel
- 27
Mantero F, Terzolo M, Arnaldi G. et al .
A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian
Society of Endocrinology.
J Clin Endocrinol Metab.
2000;
85
637-644
MissingFormLabel
- 28
Maurea S, Klain M, Mainolfi C. et al .
The diagnostic role of radionuclide imaging in evaluation of patients with nonhypersecreting
adrenal masses.
J Nucl Med.
2001;
42
884-892
MissingFormLabel
- 29
Mayo-Smith WW, Boland GW, Noto RB. et al .
State-of-the-art adrenal imaging.
Radiographics.
2001;
21
995-1012
MissingFormLabel
- 30
Ng L, Libertino JM.
Adrenocortical carcinoma: diagnosis, evaluation and treatment.
J Urol.
2003;
169
5-11
MissingFormLabel
- 31
Nieman LK, Biller BM, Findling JW. et al .
The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline.
J Clin Endocrinol Metab.
2008;
93
1526-1540
MissingFormLabel
- 32
Rossi R, Tauchmanova L, Luciano A. et al .
Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and
biochemical features.
J Clin Endocrinol Metab.
2000;
85
1440-1448
MissingFormLabel
- 33
Sirén J, Tervahartiala P, Sivula A. et al .
Natural course of adrenal incidentalomas: seven-year follow-up study.
World J Surg.
2000;
24
579-582
MissingFormLabel
- 34
Tamidari H, Mishra AK, Gupta S. et al .
Catecholamine secreting adrenal myelolipoma.
Indian J Med Sci.
2006;
60
331-333
MissingFormLabel
- 35
Terzolo M, Ali A, Osella G. et al .
Prevalence of adrenal carcinoma among incidentally discovered adrenal masses. A retrospective
study from 1989 to 1994. Gruppo Piemontese Incidentalomi Surrenalici.
Arch Surg.
1997;
132
914-919
MissingFormLabel
- 36
Terzolo M, Osella G, Alì A. et al .
Subclinical Cushing's syndrome in adrenal incidentaloma.
Clin Endocrinol (Oxf).
1998;
48
89-97
MissingFormLabel
- 37
Tsvetov G, Shimon I, Benbassat C.
Adrenal incidentaloma: clinical characteristics and comparison between patients with
and without extraadrenal malignancy.
J Endocrinol Invest.
2007;
30
647-652
MissingFormLabel
- 38
Virkkala A, Välimäki M, Pelkonen R. et al .
Endocrine abnormalities in patients with adrenal tumours incidentally discovered on
computed tomography.
Acta Endocrinol (Copenh).
1989;
121
67-72
MissingFormLabel
- 39
Young WF.
Primary aldosteronism: renaissance of a syndrome.
Clin Endocrinol (Oxf).
2007;
66
607-618
MissingFormLabel
- 40
Young Jr WF.
Clinical practice. The incidentally discovered adrenal mass.
N Engl J Med.
2007;
356
601-610
MissingFormLabel
Correspondence
P. AnagnostisMD
Endocrinology Clinic
Hippokration Hospital
49 Konstantinoupoleos straße
54642 Thessaloniki
Greece
Telefon: +30/23/1089 20 38
Fax: +30/23/1084 83 53
eMail: anagnwstis.pan@yahoo.gr